疫情防控政策全面放開(kāi),糖尿病患者應(yīng)采取積極的新冠防治措施,靈活調(diào)整治療策略。// 此外,糖尿病易引起心、腎等慢性并發(fā)癥,或合并肥胖、高血壓、血脂異常等代謝性疾病。糖尿病患者在血糖控制不佳,且未能充分補(bǔ)充液體的情況下易發(fā)生急性并發(fā)癥,尤其是糖尿病高滲狀態(tài)和酮癥酸中毒。這些疾病都會(huì)增加新冠重癥風(fēng)險(xiǎn)。因此,對(duì)于糖尿病患者而言,疫情期間也要積極控制并發(fā)癥及各種代謝紊亂。具體包括,積極控制體重,目標(biāo)體質(zhì)指數(shù)(BMI)<24kg/m2,腰圍:男性<90cm,女性<85cm;對(duì)合并高血壓的糖尿病患者,一般情況下其降壓目標(biāo)為<130/80mmHg;對(duì)于糖尿病患者的血脂控制目標(biāo),低密度脂蛋白膽固醇(LDL-C)應(yīng)控制在2.6mmol/L(100mg/dL)以下。并根據(jù)患者的動(dòng)脈粥樣硬化性心血管疾病(ASCVD)風(fēng)險(xiǎn)等級(jí),進(jìn)一步將LDL-C分層降至目標(biāo)范圍[4]。 對(duì)于合并了新冠感染的糖尿病患者,在糖尿病管理方面,要重視自我管理。以血糖控制為目標(biāo),重視“五架馬車”管理。在新冠治療方面,在兼顧血糖平穩(wěn)的同時(shí)關(guān)注治療藥物之間的相互作用,盡量降低新冠病情進(jìn)展的發(fā)生風(fēng)險(xiǎn)。
[1]Seiglie J, et al. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19[J]. Diabetes Care,2020,43(12):2938-2944. [2]Barron E, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study[J]. Lancet Diabetes Endocrinol,2020,8(10):813-822. [3]Hartmann-Boyce J, et al. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews [J]. Diabetes Care,2021,44(12):2790-2811. [4]王衛(wèi)慶,等.新型冠狀病毒肺炎疫情下糖尿病管理專家建議[J].診斷學(xué)理論與實(shí)踐,2022,21(02):136-138. [5]Marfella R, et al. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes Obes Metab. 2022 Jan;24(1):160-165. [6]中華醫(yī)學(xué)會(huì)內(nèi)分泌學(xué)分會(huì). 老年與兒童青少年糖尿病人群新型冠狀病毒感染臨床應(yīng)對(duì)指南. [7]Menni C, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study[J]. Lancet,2022,399(10335):1618-1624. |
|